208 related articles for article (PubMed ID: 38266095)
1. CYP46A1-mediated cholesterol turnover induces sex-specific changes in cognition and counteracts memory loss in ovariectomized mice.
Latorre-Leal M; Rodriguez-Rodriguez P; Franchini L; Nikolidakis O; Daniilidou M; Delac L; Varshney MK; Arroyo-García LE; Eroli F; Winblad B; Blennow K; Zetterberg H; Kivipelto M; Pacciarini M; Wang Y; Griffiths WJ; Björkhem I; Matton A; Nalvarte I; Merino-Serrais P; Cedazo-Minguez A; Maioli S
Sci Adv; 2024 Jan; 10(4):eadj1354. PubMed ID: 38266095
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology.
Burlot MA; Braudeau J; Michaelsen-Preusse K; Potier B; Ayciriex S; Varin J; Gautier B; Djelti F; Audrain M; Dauphinot L; Fernandez-Gomez FJ; Caillierez R; Laprévote O; Bièche I; Auzeil N; Potier MC; Dutar P; Korte M; Buée L; Blum D; Cartier N
Hum Mol Genet; 2015 Nov; 24(21):5965-76. PubMed ID: 26358780
[TBL] [Abstract][Full Text] [Related]
3. CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease.
Djelti F; Braudeau J; Hudry E; Dhenain M; Varin J; Bièche I; Marquer C; Chali F; Ayciriex S; Auzeil N; Alves S; Langui D; Potier MC; Laprevote O; Vidaud M; Duyckaerts C; Miles R; Aubourg P; Cartier N
Brain; 2015 Aug; 138(Pt 8):2383-98. PubMed ID: 26141492
[TBL] [Abstract][Full Text] [Related]
4. Is it possible to improve memory function by upregulation of the cholesterol 24S-hydroxylase (CYP46A1) in the brain?
Maioli S; Båvner A; Ali Z; Heverin M; Ismail MA; Puerta E; Olin M; Saeed A; Shafaati M; Parini P; Cedazo-Minguez A; Björkhem I
PLoS One; 2013; 8(7):e68534. PubMed ID: 23874659
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease.
Mast N; Saadane A; Valencia-Olvera A; Constans J; Maxfield E; Arakawa H; Li Y; Landreth G; Pikuleva IA
Neuropharmacology; 2017 Sep; 123():465-476. PubMed ID: 28655608
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease.
Fernández Del Pozo V; Alvarez Alvarez M; Fernández Martínez M; Galdós Alcelay L; Gómez Busto F; Peña JA; Alfonso-Sánchez MA; Zarranz Imirizaldu JJ; de Pancorbo MM
Dement Geriatr Cogn Disord; 2006; 21(2):81-7. PubMed ID: 16340204
[TBL] [Abstract][Full Text] [Related]
7. CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism.
Kölsch H; Lütjohann D; Jessen F; Popp J; Hentschel F; Kelemen P; Schmitz S; Maier W; Heun R
Eur Psychiatry; 2009 Apr; 24(3):183-90. PubMed ID: 19286353
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases.
Petrov AM; Pikuleva IA
Neurotherapeutics; 2019 Jul; 16(3):635-648. PubMed ID: 31001737
[TBL] [Abstract][Full Text] [Related]
9. CYP46A1 protects against NMDA-mediated excitotoxicity in Huntington's disease: Analysis of lipid raft content.
Boussicault L; Kacher R; Lamazière A; Vanhoutte P; Caboche J; Betuing S; Potier MC
Biochimie; 2018 Oct; 153():70-79. PubMed ID: 30107216
[TBL] [Abstract][Full Text] [Related]
10. CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer's disease.
Lerner AJ; Arnold SE; Maxfield E; Koenig A; Toth ME; Fortin B; Mast N; Trombetta BA; Denker J; Pieper AA; Tatsuoka C; Raghupathy S; Pikuleva IA
Alzheimers Res Ther; 2022 Dec; 14(1):198. PubMed ID: 36581878
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol 24S-Hydroxylase Overexpression Inhibits the Liver X Receptor (LXR) Pathway by Activating Small Guanosine Triphosphate-Binding Proteins (sGTPases) in Neuronal Cells.
Moutinho M; Nunes MJ; Gomes AQ; Gama MJ; Cedazo-Minguez A; Rodrigues CM; Björkhem I; Rodrigues E
Mol Neurobiol; 2015; 51(3):1489-503. PubMed ID: 25084760
[TBL] [Abstract][Full Text] [Related]
12. The potential of CYP46A1 as a novel therapeutic target for neurological disorders: An updated review of mechanisms.
Alavi MS; Karimi G; Ghanimi HA; Roohbakhsh A
Eur J Pharmacol; 2023 Jun; 949():175726. PubMed ID: 37062503
[TBL] [Abstract][Full Text] [Related]
13. CYP46A1 and the APOEε4 Allele Polymorphisms Correlate with the Risk of Alzheimer's Disease.
Li L; Zeng F; Liu YH; Li HY; Dong SY; Peng ZY; Wang YJ; Zhou HD
Mol Neurobiol; 2018 Oct; 55(10):8179-8187. PubMed ID: 29516283
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice.
Mast N; Li Y; Linger M; Clark M; Wiseman J; Pikuleva IA
J Biol Chem; 2014 Feb; 289(6):3529-38. PubMed ID: 24352658
[TBL] [Abstract][Full Text] [Related]
15. The level of 24-Hydroxycholesteryl Esters is an Early Marker of Alzheimer's Disease.
Benussi L; Ghidoni R; Dal Piaz F; Binetti G; Di Iorio G; Abrescia P
J Alzheimers Dis; 2017; 56(2):825-833. PubMed ID: 27983556
[TBL] [Abstract][Full Text] [Related]
16. Effects of CYP46A1 Inhibition on Long-Term-Depression in Hippocampal Slices
Popiolek M; Izumi Y; Hopper AT; Dai J; Miller S; Shu HJ; Zorumski CF; Mennerick S
Front Mol Neurosci; 2020; 13():568641. PubMed ID: 33192294
[TBL] [Abstract][Full Text] [Related]
17. An intronic CYP46A1 polymorphism is associated with Alzheimer disease in a Chinese Han population.
He XM; Zhang ZX; Zhang JW; Zhou YT; Wu CB; Tang MN; Hong Z
J Mol Neurosci; 2012 Jul; 47(3):514-8. PubMed ID: 22528464
[TBL] [Abstract][Full Text] [Related]
18. CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.
Boussicault L; Alves S; Lamazière A; Planques A; Heck N; Moumné L; Despres G; Bolte S; Hu A; Pagès C; Galvan L; Piguet F; Aubourg P; Cartier N; Caboche J; Betuing S
Brain; 2016 Mar; 139(Pt 3):953-70. PubMed ID: 26912634
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol-24S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina.
Bretillon L; Diczfalusy U; Björkhem I; Maire MA; Martine L; Joffre C; Acar N; Bron A; Creuzot-Garcher C
Curr Eye Res; 2007 Apr; 32(4):361-6. PubMed ID: 17453958
[TBL] [Abstract][Full Text] [Related]
20. Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels.
Fourgeux C; Martine L; Björkhem I; Diczfalusy U; Joffre C; Acar N; Creuzot-Garcher C; Bron A; Bretillon L
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5712-7. PubMed ID: 19553612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
